Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Clinical genetics

Welcome to the CdLS Community: A Guide for Families

At a Glance

Cornelia de Lange syndrome is a rare genetic condition present from birth that can affect growth, development, physical features, and multiple body systems. Diagnosis uses clinical findings and genetic testing, and a negative blood test does not always rule it out.

Receiving a diagnosis of Cornelia de Lange Syndrome (CdLS) can feel overwhelming and life-altering [1]. It is normal to feel a range of emotions as you begin to navigate this new reality for your child and your family. CdLS is a rare congenital (present from birth) genetic syndrome that occurs in approximately 1 in 10,000 to 30,000 births, though estimates vary [2][3].

It is classified as a cohesinopathy, meaning it is caused by changes in genes that help produce the cohesin complex [4]. This complex is a group of proteins that acts like a molecular ring, holding DNA together to help with cell division, DNA repair, and the way genes “turn on” or “off” during development [5]. When this process is disrupted, it affects many different systems in the body simultaneously [6].

Understanding the Diagnosis

In 2018, an international group of experts established a standardized way to diagnose CdLS [1]. Because CdLS can look very different from one child to the next, doctors often use a clinical scoring system based on physical and developmental findings to aid in diagnosis [7].

Features are divided into two main categories:

  • Cardinal Features: These are the most characteristic signs of CdLS, such as specific facial patterns (like thick or joined eyebrows) and major limb differences [1].
  • Suggestive Features: These are common in CdLS but can also be seen in other conditions, such as small head size (microcephaly) or general growth delays [1].

Under these guidelines, a clinical score of 11 or more (including at least three cardinal features) typically supports a clinical diagnosis of CdLS [1]. A score of 9 to 10 (with at least two cardinal features) is considered non-classic CdLS [1]. If a child scores 4 or higher and has at least one cardinal feature, doctors usually recommend genetic testing to investigate further [1]. However, the score is a clinical aid, not a definitive severity or prognosis scale. A pathogenic genetic variant can support a diagnosis even if the clinical score is lower, and the diagnosis must be interpreted by an experienced clinician [1].

Common Physical Hallmarks

While every child is unique, there are several physical features frequently associated with CdLS:

  • Distinctive Facial Features: This often includes synophrys (eyebrows that meet in the middle), long eyelashes, a short nose with an upturned tip, and a thin upper lip with downturned corners [6][1].
  • Growth Restriction: Children with CdLS often grow more slowly both before birth (prenatally) and after birth (postnatally) [6].
  • Microcephaly: This is the medical term for a head size that is smaller than expected for the child’s age and sex [8].
  • Limb Differences: These can range from very subtle (like small hands or a shortened fifth finger) to more significant differences, such as missing or shortened limbs (limb reduction defects) [1].
  • Increased Body Hair: You may hear doctors use the term hypertrichosis (previously referred to as hirsutism), which means generalized excess body hair that is common in children with the syndrome [6].

The CdLS Spectrum

One of the most important things to understand is that CdLS exists on a spectrum [9]. In the past, doctors mostly recognized “classic” cases where the physical features were very prominent. Today, we know that many children have “non-classic” or milder forms where the features are more subtle [1][10].

Some children may have the characteristic facial features but no limb differences at all [11]. Others may have significant developmental delays while their physical growth remains closer to the typical range [12]. The specific gene involved can influence where a child falls on this spectrum, though these categories help guide surveillance rather than strictly determining a child’s intelligence, speech, or future independence [9][13].

Addressing Early Misconceptions

When you first search for information, you may encounter outdated or confusing ideas. It is helpful to clarify a few points:

  • It is not your fault: Most genetic variants causing CdLS are de novo, meaning they happen by chance at the time of conception and were not caused by anything the parents did or did not do [6]. However, parental genetic testing and counseling are highly recommended to understand recurrence risks for future pregnancies.
  • The “Classic” look is not required: A child does not need to have joined eyebrows or missing limbs to have a CdLS diagnosis [11][1].
  • Testing can be complex: Sometimes, standard blood tests come back negative even when a child clearly has CdLS. A negative blood result does not completely exclude the syndrome. This can happen due to mosaicism, where the genetic change is present in some cells of the body but not others [14]. Depending on the suspected variant and clinical context, a genetics professional might discuss testing other tissues, like a cheek swab or skin cells [15]. A “variant of uncertain significance” (VUS) also does not establish a diagnosis on its own.
  • Development is possible: While CdLS involves developmental challenges, every child has their own trajectory. Many individuals with CdLS live well into adulthood and continue to learn and gain new skills throughout their lives [16][3].

Common questions in this guide

What is Cornelia de Lange syndrome, and what causes it?
Cornelia de Lange syndrome is a rare genetic condition present from birth that results from changes in genes involved in the cohesin complex, which helps organize DNA and guide development. Most variants happen by chance at conception and are not caused by anything a parent did or did not do. The condition can affect many body systems and varies widely from child to child.
How do doctors diagnose CdLS?
Doctors combine physical and developmental findings with international clinical criteria. A score of 11 or more, including at least three of the most characteristic features, typically supports a clinical diagnosis; lower scores may still lead to genetic testing, and a disease-causing genetic variant can support the diagnosis. An experienced clinician should interpret the score and test results together.
Can a child have CdLS without the typical facial appearance or limb differences?
Yes. CdLS is a spectrum, and some children have subtle facial features or no limb differences at all, while others have developmental delays with growth closer to the typical range. The absence of a classic appearance does not by itself rule out CdLS.
What does a negative blood genetic test mean for CdLS?
A negative blood test does not always rule out CdLS because mosaicism can mean that a genetic change is present in some cells but not others. Depending on the clinical findings and suspected variant, a genetics professional may discuss testing a cheek swab or skin cells. A variant of uncertain significance alone does not confirm a diagnosis.
Did I cause my child’s CdLS, and what about future pregnancies?
Most genetic variants that cause CdLS happen by chance at conception and are not caused by anything parents did or did not do. Testing parents and meeting with a genetic counselor can help clarify recurrence risk for future pregnancies.
What evaluations and specialists might my child need after diagnosis?
A genetics professional can help coordinate baseline evaluations and ongoing monitoring tailored to your child’s findings. The care team may recommend specialists such as gastroenterology, cardiology, and audiology, along with other services as needed.
Does a CdLS diagnosis predict my child’s development or adult independence?
No single clinical score or gene category can predict a child’s intelligence, speech, or future independence with certainty. Children with CdLS have individual developmental paths, and many continue to learn skills and live well into adulthood.

Get notified when new evidence is published on Cornelia de Lange syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement.

    Kline AD, Moss JF, Selicorni A, et al.

    Nature reviews. Genetics 2018; (19(10)):649-666 doi:10.1038/s41576-018-0031-0.

    PMID: 29995837
  2. 2

    Cornelia de Lange syndrome: What should a dermatologist know?

    Shahada O, Kurdi A, Alrohaily L, et al.

    Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2026; (35(1)):167-174 doi:10.17219/acem/201419.

    PMID: 41499064
  3. 3

    Cornelia de Lange Syndrome.

    Deschamps GN

    Neonatal network : NN 2022; (41(3)):145-149 doi:10.1891/NN-2021-0011.

    PMID: 35644361
  4. 4

    Cornelia de Lange syndrome: from molecular diagnosis to therapeutic approach.

    Sarogni P, Pallotta MM, Musio A

    Journal of medical genetics 2020; (57(5)):289-295 doi:10.1136/jmedgenet-2019-106277.

    PMID: 31704779
  5. 5

    Cornelia de Lange syndrome mutations in NIPBL can impair cohesin-mediated DNA loop extrusion.

    Panarotto M, Davidson IF, Litos G, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2022; (119(18)):e2201029119 doi:10.1073/pnas.2201029119.

    PMID: 35476527
  6. 6

    Cornelia de Lange Spectrum.

    Ascaso Á, Arnedo M, Puisac B, et al.

    Anales de pediatria 2024; (100(5)):352-362 doi:10.1016/j.anpede.2024.04.012.

    PMID: 38735830
  7. 7

    Phenotypes of Cornelia de Lange syndrome caused by non-cohesion genes: Novel variants and literature review.

    Shangguan H, Chen R

    Frontiers in pediatrics 2022; (10()):940294 doi:10.3389/fped.2022.940294.

    PMID: 35935361
  8. 8

    A 16-Day-Old Infant with a Clinical Diagnosis of Classical Cornelia de Lange Syndrome.

    Rodríguez P, Asturias K

    Case reports in pediatrics 2020; (2020()):6482938 doi:10.1155/2020/6482938.

    PMID: 32328333
  9. 9

    Cornelia de Lange Syndrome: From a Disease to a Broader Spectrum.

    Selicorni A, Mariani M, Lettieri A, Massa V

    Genes 2021; (12(7)) doi:10.3390/genes12071075.

    PMID: 34356091
  10. 10

    Chromatinopathies: A focus on Cornelia de Lange syndrome.

    Avagliano L, Parenti I, Grazioli P, et al.

    Clinical genetics 2020; (97(1)):3-11 doi:10.1111/cge.13674.

    PMID: 31721174
  11. 11

    De novo heterozygous mutations in SMC3 cause a range of Cornelia de Lange syndrome-overlapping phenotypes.

    Gil-Rodríguez MC, Deardorff MA, Ansari M, et al.

    Human mutation 2015; (36(4)):454-62 doi:10.1002/humu.22761.

    PMID: 25655089
  12. 12

    A de novo start-loss variant in the NIPBL gene causing mild type 1 Cornelia de Lange syndrome in an Iranian family: A Case Report.

    Mir A, Abbasi Z, Song Y, et al.

    Journal of medical case reports 2026; (20(1)).

    PMID: 42069659
  13. 13

    Pathogenic variants in EP300 and ANKRD11 in patients with phenotypes overlapping Cornelia de Lange syndrome.

    Cucco F, Sarogni P, Rossato S, et al.

    American journal of medical genetics. Part A 2020; (182(7)):1690-1696 doi:10.1002/ajmg.a.61611.

    PMID: 32476269
  14. 14

    A series of 38 novel germline and somatic mutations of NIPBL in Cornelia de Lange syndrome.

    Nizon M, Henry M, Michot C, et al.

    Clinical genetics 2016; (89(5)):584-9 doi:10.1111/cge.12720.

    PMID: 26701315
  15. 15

    Clinical relevance of postzygotic mosaicism in Cornelia de Lange syndrome and purifying selection of NIPBL variants in blood.

    Latorre-Pellicer A, Gil-Salvador M, Parenti I, et al.

    Scientific reports 2021; (11(1)):15459 doi:10.1038/s41598-021-94958-z.

    PMID: 34326454
  16. 16

    Age-related Behavioural Change in Cornelia de Lange and Cri du Chat Syndromes: A Seven Year Follow-up Study.

    Cochran L, Welham A, Oliver C, et al.

    Journal of autism and developmental disorders 2019; (49(6)):2476-2487 doi:10.1007/s10803-019-03966-6.

    PMID: 30941551

This page is for informational purposes only and does not constitute medical advice. A clinical geneticist and your child’s care team should interpret the diagnosis, test results, and care needs.